Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virusTakako Inoue, Yasuhito Tanaka, Shunsuke Nojiri et al.|Hepatology Research|2017Cited by 41
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control studyKosuke Matsumoto, Atsushi Tanaka, Satoko Ohfuji et al.|Journal of Gastroenterology|2021Cited by 34
Novel strategies for the early diagnosis of hepatitis B virus reactivationTakako Inoue, Yasuhito Tanaka, Takeshi Matsui|Hepatology Research|2021Cited by 19
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis BYoshihito Nagura, Yasuhito Tanaka, Kentaro Matsuura et al.|PLoS ONE|2022Cited by 9